Table 3.
Echocardiographic comparisons of lymphoma group (n = 13) and control group (n = 12), and the effect of 24 hours of fluid therapy on lymphoma measurements.
| Control | Lymphoma Baseline | 4 Hours | 24 Hours | |
|---|---|---|---|---|
| 2D LA (cm) | 3.7 ± 0.4a | 3.1 ± 0.9 | 3.4 ± 0.9b | 3.5 ± 0.8b |
| LV EDV (mL) | 60.3 ± 12.3a | 43.2 ± 15.8 | 46.5 ± 25.4 | 50.4 ± 25.9b |
| LV ESV (mL) | 22.1 ± 9.8 | 15.2 ± 7.9 | 15.1 ± 9.1 | 17.2 ± 10.0 |
| Stroke volume (mL) | 38.2 ± 10.5 | 30.7 ± 16.3 | 31.4 ± 17.4 | 33.2 ± 17.0 |
| MM LA (cm) | 2.8 ± 0.4a | 2.4 ± 0.5 | 2.6 ± 0.6 | 2.6 ± 0.5 |
| MM LA/Ao | 1.2 ± 0.2 | 1.2 ± 0.2 | 1.3 ± 0.2 | 1.3 ± 0.2 |
| MM LVIDd (cm) | 3.9 ± 0.6a | 3.4 ± 0.7 | 3.5 ± 0.8 | 3.6 ± 0.8b |
| MM LVIDs (cm) | 2.7 ± 0.5a | 2.2 ± 0.7 | 2.3 ± 0.7 | 2.4 ± 0.7 |
| MM IVSd (cm) | 1.0 ± 0.2 | 0.9 ± 0.2 | 0.9 ± 0.3 | 0.9 ± 0.2 |
| MM LVPWd (cm) | 0.9 ± 0.2 | 0.9 ± 0.3 | 0.9 ± 0.2 | 0.9 ± 0.2 |
| FS (%) | 33 ± 5 | 36 ± 9 | 35 ± 6 | 35 ± 8 |
| MFV E wave (m/s) | 0.7 ± 0.2 | 0.8 ± 0.2 | 0.8 ± 0.2 | 0.8 ± 0.2 |
| MFV A wave (m/s) | 0.6 ± 0.2 | 0.6 ± 0.2 | 0.6 ± 0.2 | 0.6 ± 0.2 |
| MFV slope (m/s2) | 6.6 ± 2.8 | 6.1 ± 1.9 | 6.4 ± 1.5 | 7.0 ± 2.8 |
| LV SAAd (cm2) | 13.6 ± 3.2a | 10.0 ± 3.7 | 10.4 ± 3.5 | 11.6 ± 4.2b |
| LV SAAs (cm2) | 6.2 ± 2.2a | 4.1 ± 2.3 | 4.4 ± 2.1 | 5.1 ± 2.6b |
| Ao velocity (m/s) | 1.3 ± 0.3 | 1.4 ± 0.9 | 1.6 ± 0.8 | 1.3 ± 0.6 |
| CI (L/min/M2) | 3.7 ± 1.1 | 3.2 ± 1.2 | 3.6 ± 0.9 | 3.6 ± 0.9 |
Significant difference between control group and lymphoma baseline.
Significant difference between indicated time point and lymphoma baseline.
2D, two‐dimensional; Ao, aorta; CI, cardiac index; FS, fractional shortening, LA, left atrium; LA/Ao, left atrial to aortic root ratio; LV, left ventricular; EDV, end‐diastolic volume; ESV, end‐systolic volume; LVIDd, left ventricular internal diameter in diastole; LVIDs, left ventricular internal diameter in systole; MFV, transmitral filling velocity; MM, M‐mode; PG, pressure gradient; SAAd, short‐axis area in diastole; SAAs, short‐axis area in systole.